What is the equity of Roche Holding this year?
Roche Holding has equity of 29.32 B CHF this year.
In 2024, Roche Holding's equity was 29.32 B CHF, a 4.73% increase from the 27.99 B CHF equity in the previous year.
Roche Holding's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Roche Holding's equity is essential for assessing its financial health, stability, and value to shareholders.
Evaluating Roche Holding's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.
Roche Holding's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.
Fluctuations in Roche Holding’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.
Roche Holding has equity of 29.32 B CHF this year.
The equity of Roche Holding has increased/decreased by 4.73% increased compared to the previous year.
A high equity is advantageous for investors of Roche Holding as it is an indicator of the company's financial stability and its ability to manage risks and challenges.
A low equity can be a risk for investors of Roche Holding, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.
An increase in equity of Roche Holding can strengthen the company's financial position and improve its ability to make investments in the future.
A reduction in equity of Roche Holding can affect the financial situation of the company and lead to a higher dependence on debt capital.
Some factors that can affect the equity of Roche Holding include profits, dividend payments, capital increases, and acquisitions.
The equity of Roche Holding is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.
To change equity, Roche Holding can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.
Over the past 12 months, Roche Holding paid a dividend of 9.5 CHF . This corresponds to a dividend yield of about 4.32 %. For the coming 12 months, Roche Holding is expected to pay a dividend of 11.25 CHF.
The current dividend yield of Roche Holding is 4.32 %.
Roche Holding pays a quarterly dividend. This is distributed in the months of April, April, April, April.
Roche Holding paid dividends every year for the past 37 years.
For the upcoming 12 months, dividends amounting to 11.25 CHF are expected. This corresponds to a dividend yield of 5.08 %.
Roche Holding is assigned to the 'Health' sector.
To receive the latest dividend of Roche Holding from 3/18/2024 amounting to 9.6 CHF, you needed to have the stock in your portfolio before the ex-date on 3/14/2024.
The last dividend was paid out on 3/18/2024.
In the year 2023, Roche Holding distributed 9.3 CHF as dividends.
The dividends of Roche Holding are distributed in CHF.
Our stock analysis for Roche Holding Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Roche Holding Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.